Company Filing History:
3 out of 932 
1 out of 23 
Years Active: 2010-2025
Title: Innovations in Cancer Detection by Helen Merkens
Introduction
Helen Merkens is a notable inventor based in Burnaby, Canada, recognized for her significant contributions to cancer detection and treatment. With two patents to her name, she has made strides in developing methods that enhance the monitoring and diagnosis of cancer.
Latest Patents
Her latest patents focus on innovative methods for detecting and treating cancer. These patents describe methods and kits that analyze samples containing nucleic acids or proteins from patients. The analysis aims to identify decreased expression of endoglycan and/or increased expression of podocalyxin, which are crucial indicators in cancer progression.
Career Highlights
Helen Merkens is affiliated with the University of British Columbia, where she continues her research and development in the field of oncology. Her work is pivotal in advancing the understanding of cancer biomarkers and improving patient outcomes through early detection.
Collaborations
Some of her notable coworkers include Kelly Marshall McNagny and Calvin D Roskelley, who contribute to her research endeavors and collaborative projects.
Conclusion
Helen Merkens exemplifies the innovative spirit in the field of cancer research, with her patents paving the way for improved diagnostic methods. Her work continues to impact the medical community and offers hope for better cancer management.